Moreover, loss of Wnt/β-catenin signaling induces AD-like neuropathological hallmarks in wild-type mice, and accelerates the development of AD-like pathology in an AD mouse model overexpressed human APP with two FAD mutations [76]. The gene discussed is APP; the disease is Alzheimer disease.